ECM
Endurant Capital Management Portfolio holdings
AUM
$17.4M
This Quarter Return
+3.42%
1 Year Return
+4.95%
3 Year Return
+16.8%
5 Year Return
+58.39%
10 Year Return
–
AUM
$327M
AUM Growth
+$327M
(+0.32%)
Cap. Flow
-$6.22M
Cap. Flow
% of AUM
-1.9%
Top 10 Holdings %
Top 10 Hldgs %
34.51%
Holding
106
New
22
Increased
29
Reduced
23
Closed
31
Top Buys
| 1 |
WBA
Walgreens Boots Alliance
WBA
|
$10.6M |
| 2 |
Medtronic
MDT
|
$7.15M |
| 3 |
Merck
MRK
|
$5.97M |
| 4 |
WMGI
Wright Medical Group Inc
WMGI
|
$5.9M |
| 5 |
AGN
Allergan plc
AGN
|
$5.89M |
Top Sells
| 1 |
Pfizer
PFE
|
$8.12M |
| 2 |
Universal Health Services
UHS
|
$7.89M |
| 3 |
Biogen
BIIB
|
$7.78M |
| 4 |
BCR
CR Bard Inc.
BCR
|
$5.49M |
| 5 |
NSTG
NanoString Technologies, Inc.
NSTG
|
$4.77M |
Sector Composition
| 1 | Healthcare | 86.13% |
| 2 | Real Estate | 3.64% |
| 3 | Financials | 2.17% |
| 4 | Technology | 0.3% |
| 5 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Cencora
COR
$56.5B
| $5.07M | 1.55% |
55,240
+21,500
| +64% | +$1.97M |
|
|
SHPG
27
DELISTED
Shire pic
SHPG
| $5.07M | 1.55% |
32,696
-22,600
| -41% | -$3.51M |
|
28
Elevance Health
ELV
$71.8B
| $5.07M | 1.55% |
22,511
-10,300
| -31% | -$2.32M |
|
29
Viatris
VTRS
$12.3B
| $5.03M | 1.54% |
118,887
-12,513
| -10% | -$529K |
|
|
SYNH
30
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $4.92M | 1.5% |
+112,900
| New | +$4.92M |
|
|
31
Biogen
BIIB
$19.4B
| $4.91M | 1.5% |
15,399
-24,418
| -61% | -$7.78M |
|
|
ENTL
32
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
| $4.62M | 1.41% |
189,268
-19,503
| -9% | -$476K |
|
|
CLVS
33
DELISTED
Clovis Oncology, Inc.
CLVS
| $4.6M | 1.41% |
67,650
+10,900
| +19% | +$741K |
|
34
Becton Dickinson
BDX
$55.3B
| $4.3M | 1.31% |
20,070
+6,069
| +43% | +$1.3M |
|
|
CELG
35
DELISTED
Celgene Corp
CELG
| $3.95M | 1.21% |
37,800
+21,500
| +132% | +$2.24M |
|
36
CVS Health
CVS
$92.8B
| $3.86M | 1.18% |
53,300
+25,800
| +94% | +$1.87M |
|
37
Fate Therapeutics
FATE
$120M
| $3.4M | 1.04% |
556,679
+283,979
| +104% | +$1.73M |
|
38
Labcorp
LH
$23.1B
| $3.28M | 1% |
+20,575
| New | +$3.28M |
|
39
Baxter International
BAX
$12.7B
| $3.25M | 0.99% |
50,249
+29,500
| +142% | +$1.91M |
|
40
Amicus Therapeutics
FOLD
$2.34B
| $2.97M | 0.91% |
+206,400
| New | +$2.97M |
|
41
Puma Biotechnology
PBYI
$254M
| $2.96M | 0.9% |
29,900
+8,500
| +40% | +$840K |
|
|
KA
42
DELISTED
Kineta, Inc. Common Stock
KA
| $2.83M | 0.86% |
+485,012
| New | +$2.83M |
|
43
Stryker
SYK
$150B
| $2.77M | 0.85% |
17,867
-7,237
| -29% | -$1.12M |
|
44
Sarepta Therapeutics
SRPT
$1.78B
| $2.72M | 0.83% |
48,800
-18,500
| -27% | -$1.03M |
|
|
AERI
45
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $2.71M | 0.83% |
45,366
-11,822
| -21% | -$706K |
|
46
Medpace
MEDP
$13.4B
| $2.29M | 0.7% |
+63,100
| New | +$2.29M |
|
47
Regeneron Pharmaceuticals
REGN
$61.5B
| $2.11M | 0.64% |
+5,600
| New | +$2.11M |
|
|
NVRO
48
DELISTED
NEVRO CORP.
NVRO
| $1.86M | 0.57% |
26,961
-12,500
| -32% | -$863K |
|
49
Humana
HUM
$36.5B
| $1.69M | 0.52% |
+6,800
| New | +$1.69M |
|
|
ARA
50
DELISTED
American Renal Associates Holdings, Inc
ARA
| $1.55M | 0.47% |
89,129
-6,827
| -7% | -$119K |
|